A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...
While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 ...
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...